Affordable Access

Publisher Website

Intranasal Beclomethasone as an Adjunct to Treatment of Chronic Middle Ear Effusion

Authors
Journal
Annals of Allergy Asthma & Immunology
1081-1206
Publisher
Elsevier
Publication Date
Volume
80
Issue
2
Identifiers
DOI: 10.1016/s1081-1206(10)62956-0
Disciplines
  • Medicine

Abstract

Background Following otitis media, 10% to 50% of children develop residual middle ear effusion with concurrent hearing loss and potential cognitive, behavioral, and language impairment. Prophylactic antibiotics and tympanostomy tubes are currently recommended treatments for chronic middle ear effusion. Objective In a double-blind, placebo-controlled, randomized study of chronic middle ear effusion, we assessed the effectiveness of topical intranasal beclomethasone as an adjunct to prophylactic antibiotic therapy. Methods Sixty-one children, aged 3 to 11 years with persistent middle ear effusion greater than 3 months, were randomized into three treatment groups: (1) prophylactic antibiotics, (2) prophylactic antibiotics plus intranasal beclomethasone (336 micrograms/day); and (3) prophylactic antibiotics plus intranasal placebo. Patients were evaluated with aerollergen skin tests at entry; and tympanogram, otoscopic examination, and symptom questionnaire at 0, 4, 8, and 12 weeks. Results While middle ear pressures, otoscopic examinations, and symptom scores were improved for each treatment group over 12 weeks of therapy, the beclomethasone plus antibiotics group improved all three measures more rapidly than the antibiotics-alone and placebo nasal spray plus antibiotics group over the first 8 weeks. Only the beclomethasone group significantly improved left (P = .004) and right (P = .01) middle ear pressures over 12 weeks. Resolution of chronic middle ear effusions was more frequent in the beclomethasone group (P </= .05 at 4 and 8 weeks). No difference in response to nasal steroids was observed betweeen atopic and nonatopic subjects. Conclusions We conclude that intranasal beclomethasone may be a useful adjunct to prophylactic antibiotic treatment of chronic middle ear effusion.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Intranasal beclomethasone as an adjunct to treatme...

on Annals of Allergy Asthma & Imm... February 1998

Beclomethasone nasal spray in the treatment of mid...

on International Journal of Pedia... Jan 01, 1982

Beclomethasone nasal spray in the treatment of mid...

on International journal of pedia... June 1982
More articles like this..